• SvenskaSvenska
Active Biotech
  • Home
  • About
    • Active Biotech in Brief
    • Board of Directors
    • Management
    • Business Concept
    • Corporate Governance
      • Corporate Governance Report 2022
      • Article of Association
      • Audit committee
      • Scientific committee
      • Election Committee
      • General Meetings
      • Auditors
    • Partnerships
    • Career
    • Privacy Policy
  • Projects
    • Project Overview
    • Tasquinimod
      • Tasquinimod
      • This is tasquinimod
      • Multiple myeloma
      • The market for treatment of multiple myeloma
      • Current treatments
      • Tasquinimod in multiple myeloma
      • Ongoing clinical development
      • Myelofibrosis
      • Current treatments and market
      • Tasquinimod in myelofibrosis
      • Previous clinical experience
      • Clinical studies
      • Publications
    • Laquinimod
      • Laquinimod
      • This is laquinimod
      • Non-Infectious Uveitis
      • The market
      • Current treatments
      • Laquinimod in non-infectious uveitis
      • Clinical development
      • Previous clinical experience
      • Clinical studies
      • Publications
    • Naptumomab
      • Naptumomab
      • This is naptumomab
      • Solid tumors
      • The market
      • Current treatments
      • Naptumomab in solid tumors
      • Ongoing clinical development
      • Previous clinical experience
      • Clinical studies
      • Publications
    • Patents
    • Orphan Drug Designation
  • Investor
    • Investor
    • Equity research and Presentations
    • Analysts
    • Capital Markets Day 2020
    • Financial Calendar
    • Financial Reports
    • Stock
    • Ownership
    • Official Documents
      • Rights Issue 2022
      • Rights Issue 2021
      • Rights Issue 2018
      • Rights Issue 2016
      • Rights Issue 2014
    • Events
  • Media
    • Press Contact
    • Press Releases
      • Subscribe
    • Image Bank
  • Contact
Copyright © 2023 Active Biotech AB. All Rights Reserved.
Design by Clavis Communications.

Media

  • Press Contact
  • Press Releases
    • Subscribe
  • Image Bank

Press Releases

  • Clinical safety and preclinical ocular biodistribution for laquinimod eye drops presented at the IOIS meeting available at Active Biotech’s website
    Sep 13, 2023 08:30 (CEST)
  • Tasquinimod successfully completes dose optimization in patients with multiple myeloma and advances into the pre-planned expansion cohort
    Sep 11, 2023 08:30 (CEST)
  • Active Biotech Interim Report Q2 2023
    Aug 24, 2023 08:30 (CEST) Regulatory
  • Active Biotech enters into clinical trial collaboration agreement for a clinical study with tasquinimod in myelofibrosis
    Jul 31, 2023 08:30 (CEST)
  • Safety and ocular biodistribution support development of laquinimod eye drops for inflammatory eye disorders
    May 30, 2023 11:30 (CEST)

Content

  • Home
  • About
  • Projects
  • Investor
  • Media
  • Contact

Postal Address

Active Biotech AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Visiting Address

Active Biotech AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

+46 46 19 20 00
info@activebiotech.com

Data Protection Officer (DPO)
dataprotection@activebiotech.com

LinkedIn

Copyright © 2023 Active Biotech AB. All Rights Reserved.
Design by Clavis Communications.
We use cookies on our website to give you the most relevant experience by remembering your preferences. By clicking “Accept All”, you consent to the use of ALL the cookies, by clicking "Deny All", you reject ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie Settings Deny All Accept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use functional cookies to store settings for this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Functional
Functional cookies help to perform certain functionalities like saving the selected language.
CookieDurationDescription
pll_language12 monthsCookie used to store selected language on www.activebiotech.com. It does not store any personal data.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-functional12 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". It does not store any personal data.
cookielawinfo-checkbox-necessary12 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". It does not store any personal data.
CookieLawInfoConsent12 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy12 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
SAVE & ACCEPT